Uncategorized

First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy. — Like For Real Dough

First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy. https://ift.tt/2Dj6dnH

via First ever HIV immunotherapy, involving ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals, proves safe in human phase 1 clinical trial, as reported in the journal Molecular Therapy. — Like For Real Dough

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s